Long-Term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic Malignancies

CONTEXT: A minimally toxic nonmyeloablative regimen was developed for allogeneic hematopoietic cell transplantation (HCT) to treat patients with advanced hematologic malignancies who are older or have comorbidities. OBJECTIVE: To describe outcomes of patients ≥ 60 years. DESIGN, SETTING, AND PARTICI...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Sorror, Mohamed L., Sandmaier, Brenda M., Storer, Barry E., Franke, Georg N., Laport, Ginna G., Chauncey, Thomas R., Agura, Edward, Maziarz, Richard T., Langston, Amelia, Hari, Parameswaran, Pulsipher, Michael A., Bethge, Wolfgang, Sahebi, Firoozeh, Bruno, Benedetto, Maris, Michael B., Yeager, Andrew, Petersen, Finn Bo, Vindeløv, Lars, McSweeney, Peter A., Hübel, Kai, Mielcarek, Marco, Georges, George E., Niederwieser, Dietger, Blume, Karl G., Maloney, David G., Storb, Rainer
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2011
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3217787/
https://ncbi.nlm.nih.gov/pubmed/22045765
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2011.1558
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg